Start Trading Now Get Started
Advertiser Disclosure
Advertiser Disclosure DailyForex.com adheres to strict guidelines to preserve editorial integrity to help you make decisions with confidence. Some of the reviews and content we feature on this site are supported by affiliate partnerships from which this website may receive money. This may impact how, where and which companies / services we review and write about. Our team of experts work to continually re-evaluate the reviews and information we provide on all the top Forex / CFD brokerages featured here. Our research focuses heavily on the broker’s custody of client deposits and the breadth of its client offering. Safety is evaluated by quality and length of the broker's track record, plus the scope of regulatory standing. Major factors in determining the quality of a broker’s offer include the cost of trading, the range of instruments available to trade, and general ease of use regarding execution and market information.

AbbVie (ABBV) Stock Signal: How Strong is the Double Top Formation?

By Adam Lemon

Adam Lemon began his role at DailyForex in 2013 when he was brought in as an in-house Chief Analyst. Adam trades Forex, stocks and other instruments in his own account. Adam believes that it is very possible for retail traders/investors to secure a positive return over time provided they limit their risks, follow trends, and persevere through short-term losing streaks – provided only reputable brokerages are used. He has previously worked with...

Read more

Short Trade Idea

Enter your short position between 195.82 (the lower band of its horizontal resistance zone) and 199.89 (yesterday’s intra-day high).

Market Index Analysis

  • AbbVie (ABBV) is a member of the S&P 100 and the S&P 500.
  • Both indices trade near their record high, but bearish trading volumes raise a red flag.
  • The Bull Bear Power Indicator of the S&P 500 shows a negative divergence.

Market Sentiment Analysis

The bond market bets on three interest rate cuts after the dismal Friday’s NFP report and yesterday’s ISM services reading confirmed a standstill in the services sector, which accounts for over 70% of economic activity. Equity markets corrected, and AI darling AMD disappointed with its second-quarter earnings report, while remaining upbeat on AI. The inflation risk of tariffs is uncertain, credit card debt is at an all-time high, and the Federal Reserve faces a challenging September meeting. More volatility lies ahead in what could be a red August for equity markets.

AbbVie Fundamental Analysis

AbbVie is a pharmaceutical company that ranks seventh among the largest pharmaceutical companies by revenue, with a growing presence in neuroscience, bolstered by a robust product portfolio.

So, why am I bearish on ABBV after its recent rally?

The excessive valuation and high debt level worry me. Its active pipeline is not as deep as its core competitors, and I cannot ignore its negative earnings growth. Tariffs on pharmaceuticals and their impact on the US healthcare system are an unknown factor that could add downside pressure on AbbVie. The deteriorating technical picture could trigger a profit-taking sell-off.

AbbVie Fundamental Analysis Snapshot

AbbVie Fundamental Analysis Snapshot

The price-to-earnings (P/E) ratio of 94.55 makes ABBV an expensive stock. By comparison, the P/E ratio for the S&P 500 is 28.79.

The average analyst price target for ABBV is 214.24. It points to decent upside potential, but downside risks are greater.

Top Forex Brokers

1
Get Started 74% of retail CFD accounts lose money Read Review

AbbVie Technical Analysis

Today’s ABBV Signal

AbbVie Stock Signal 06/08: Double Top Formation (Chart)

  • The ABBV D1 chart shows price action has formed a double top, a bearish chart pattern.
  • It also shows price action near its 0.0% Fibonacci Retracement Fan level.
  • The Bull Bear Power Indicator is bullish, but with a descending trendline.
  • Bearish trading volumes are notably higher than bullish trading volumes.
  • ABBV pushed higher with the S&P 500, but remains exposed to a sell-off amid technical cracks in the rally.

My Call

I am taking a short position in ABBV between 195.82 and 199.89. The high valuation and debt levels have combined with a weakening technical outlook. Therefore, I believe we are in for a correction, and I will sell the rally.

  • ABBV Entry Level: Between 195.82 and 199.89
  • ABBV Take Profit: Between 164.39 and 168.54
  • ABBV Stop Loss: Between 207.22 and 210.69
  • Risk/Reward Ratio: 2.76

Ready to trade our free trading signals? We’ve made a list of the top 10 forex brokers in the world for you to check out.

Adam Lemon began his role at DailyForex in 2013 when he was brought in as an in-house Chief Analyst. Adam trades Forex, stocks and other instruments in his own account. Adam believes that it is very possible for retail traders/investors to secure a positive return over time provided they limit their risks, follow trends, and persevere through short-term losing streaks – provided only reputable brokerages are used. He has previously worked within financial markets over a 12-year period, including 6 years with Merrill Lynch.

Most Visited Forex Broker Reviews